To explore the association between CRIF1 expression and the clinicopathological features and clinical outcomes of HCC patients, CRIF1 expression was evaluated by the immunohistochemistry (IHC) analysis in tumor tissues from 183 patients with HCC. Here, GADD45GIP1 is linked to neoplasm.